In this episode, Dr Ashleigh Hull and Dr Stephen Tronchin join host Liz Williams to explore theranostics — a cutting-edge approach to cancer treatment that uses radiopharmaceuticals to both detect and treat cancers from within the body. They cover the science behind how these treatments are designed to target cancer cells, which cancers theranostics is already being used for, and the real-world supply chain challenges that determine how many patients can access these therapies. The episode closes with a look at what's on the horizon for the field in Australia and globally.

Dr Ashleigh Hull is a nuclear medicine technologist and lecturer in medical physics, and Dr Stephen Tronchin is a post-doctoral research fellow. Both work at Adelaide University and are part of  ...